Earle, David
,
Roth, J. Scott
Saber, Alan
Haggerty, Steve
Bradley, Joel F. III
Fanelli, Robert
Price, Raymond
Richardson, William S.
Stefanidis, Dimitrios
Article History
Received: 2 March 2016
Accepted: 21 June 2016
First Online: 12 July 2016
Compliance with ethical standards
:
: Dr. Roth receives PI research, consulting/speaking fees for Bard. He also receives PI research, speaking fees for WL Gore and LifeCell. He receives PI research, consulting stock for Miromatrix. He also receives PI research, speaking fees for MTF. Dr. Earle receives honoraria/speaking fees for Atrium Medical. He also receives consulting fees for Bard, DSM Biosurgical, and RTI Biologics. He has an ownership stake and is on the advisory board for EndoSphere. He receives a grant for Foundation for Surgical Fellowships. He has an ownership stake and receives consulting fees for Surgiquest. He also has an ownership stake and is on the advisory board on Via Surgical. Dr. Fanelli receives royalties from Cook Inc. for inventions unrelated to current work. He is a consultant and advisor for EndoGastric Solutions, Inc. He has minority ownership interest in Allurion Technologies, Mozaic Medical, and Respiratory Motion, Inc. Dr. Haggerty is a consultant and speaker for Covidien/Medtronic (Renal Division), as well as receiving honoraria from Bard. Dr. Stefanidis receives honoraria for teaching from WL Gore and Davol. He receives research support for Ethicon. Drs. Bradley, Saber, Price, and Richardson have no conflicts of interest or financial ties to disclose.